Bioharvest Sciences Valuation
| CNVCF Stock | USD 6.15 0.07 1.13% |
At this time, the firm appears to be overvalued. Bioharvest Sciences shows a prevailing Real Value of $4.92 per share. The current price of the firm is $6.15. Our model approximates the value of Bioharvest Sciences from analyzing the firm fundamentals such as Current Valuation of 106.97 M, return on equity of -63.64, and Profit Margin of (2.69) % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Bioharvest Sciences' price fluctuation is moderately volatile at this time. Calculation of the real value of Bioharvest Sciences is based on 3 months time horizon. Increasing Bioharvest Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bioharvest otc stock is determined by what a typical buyer is willing to pay for full or partial control of Bioharvest Sciences. Since Bioharvest Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bioharvest OTC Stock. However, Bioharvest Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.15 | Real 4.92 | Hype 6.15 |
The real value of Bioharvest OTC Stock, also known as its intrinsic value, is the underlying worth of Bioharvest Sciences OTC Stock, which is reflected in its stock price. It is based on Bioharvest Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bioharvest Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bioharvest Sciences helps investors to forecast how Bioharvest otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bioharvest Sciences more accurately as focusing exclusively on Bioharvest Sciences' fundamentals will not take into account other important factors: Bioharvest Sciences Total Value Analysis
Bioharvest Sciences is currently forecasted to have takeover price of 106.97 M with market capitalization of 75.88 M, debt of 3.97 M, and cash on hands of 1.21 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bioharvest Sciences fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
106.97 M | 75.88 M | 3.97 M | 1.21 M |
Bioharvest Sciences Investor Information
About 35.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Bioharvest Sciences had not issued any dividends in recent years. Based on the key indicators related to Bioharvest Sciences' liquidity, profitability, solvency, and operating efficiency, Bioharvest Sciences is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Bioharvest Sciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bioharvest Sciences has an asset utilization ratio of 20.59 percent. This implies that the OTC Stock is making $0.21 for each dollar of assets. An increasing asset utilization means that Bioharvest Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Bioharvest Sciences Ownership Allocation
Bioharvest Sciences holds a total of 460.72 Million outstanding shares. Bioharvest Sciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bioharvest Sciences Profitability Analysis
The company reported the revenue of 2.1 M. Net Loss for the year was (9.83 M) with profit before overhead, payroll, taxes, and interest of 670 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bioharvest Sciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bioharvest Sciences and how it compares across the competition.
About Bioharvest Sciences Valuation
The otc valuation mechanism determines Bioharvest Sciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Bioharvest Sciences. We calculate exposure to Bioharvest Sciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bioharvest Sciences's related companies.BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product and medical cannabis. Canna-V-Cell Sciences is traded on OTC Exchange in the United States.
8 Steps to conduct Bioharvest Sciences' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Bioharvest Sciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bioharvest Sciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bioharvest Sciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bioharvest Sciences' revenue streams: Identify Bioharvest Sciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bioharvest Sciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bioharvest Sciences' growth potential: Evaluate Bioharvest Sciences' management, business model, and growth potential.
- Determine Bioharvest Sciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bioharvest Sciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Bioharvest Sciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Bioharvest Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 452.7 M | |
| Retained Earnings | -59.7 M |
Complementary Tools for Bioharvest OTC Stock analysis
When running Bioharvest Sciences' price analysis, check to measure Bioharvest Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioharvest Sciences is operating at the current time. Most of Bioharvest Sciences' value examination focuses on studying past and present price action to predict the probability of Bioharvest Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioharvest Sciences' price. Additionally, you may evaluate how the addition of Bioharvest Sciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |